Feb 2011

Home >> Clinical Trials News Archive >> 2011 >> Feb 2011

Israeli economy expands rapidly in 4th quarter. Israel economy grew at annual rate of 7.8 percent in the fourth quarter of 2010, bucking the trend of sluggish growth in most developed countries around the world.

Perrigo Israel buys Paddock Laboratories, a private Minneapolis-based company produces specialty generic drugs,  for $540m.

Study: Longer data exclusivity for sponsors would increase innovation, extend life expectancy. If drugmakers were able to extend their clinical trial data exclusivity to 12 years, it would result in 228 new drugs over the next 50 years and extend the average life expectancy of Americans by 1.7 months.Those are the assertions of researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy and Economics.

PwC: Israel being overtaken in medical devices. Israel's start-ups are considered one of the country's competitive advantages in the global high-tech and life sciences industries. However, a new report by PricewaterhouseCoopers LLP (PwC) says that emerging economies are breathing down Israel's neck and may have already passed it.